Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE - Lyu, Mi-Ae; Tang, Ximing; Raso, Maria Gabriela; Huang, Meixian; Zeng, Ke; Sadeghi, Tara; Flowers, Christopher R.; Parmar, Simrit (Frontiers in Immunology, 2025)